February 16, 2010 — The quadrivalent vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (Gardasil, Merck & Co) results in statistically significant reductions of HPV-associated genital diseases, such as warts and cervical dysplasia, in young women who receive it, according to the final analysis of 2 randomized placebo-controlled efficacy trials.
Read more...
Source:
http://cme.medscape.com
Saturday, February 27, 2010
HPV VACCINE REDUCES RATES OF GENITAL DISEASES IN YOUNG WOMEN
Saturday, February 27, 2010Labels: Flu Vaccine, Health, HPV, HPV vaccine, Sex change, Sexuality, STD, Vaccine
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment